Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medically Uninsured | 5 | 2017 | 104 | 2.690 |
Why?
|
Emergency Service, Hospital | 9 | 2020 | 1222 | 1.940 |
Why?
|
Emergency Medicine | 3 | 2018 | 146 | 1.520 |
Why?
|
Insurance Coverage | 3 | 2017 | 273 | 1.060 |
Why?
|
Medicaid | 3 | 2017 | 312 | 1.040 |
Why?
|
Patient Transfer | 2 | 2017 | 139 | 1.020 |
Why?
|
Diagnostic Errors | 3 | 2020 | 524 | 0.860 |
Why?
|
Aftercare | 3 | 2017 | 258 | 0.740 |
Why?
|
Health Expenditures | 3 | 2017 | 218 | 0.730 |
Why?
|
Medical Overuse | 2 | 2018 | 52 | 0.720 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2017 | 109 | 0.710 |
Why?
|
Orthopedics | 3 | 2017 | 75 | 0.660 |
Why?
|
Electronic Health Records | 3 | 2020 | 987 | 0.630 |
Why?
|
Emergency Medical Services | 3 | 2020 | 445 | 0.610 |
Why?
|
Deinstitutionalization | 1 | 2017 | 3 | 0.610 |
Why?
|
Patient Discharge | 3 | 2017 | 720 | 0.600 |
Why?
|
Emergency Services, Psychiatric | 1 | 2017 | 22 | 0.590 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 80 | 0.550 |
Why?
|
Stroke Rehabilitation | 1 | 2016 | 60 | 0.550 |
Why?
|
Health Information Exchange | 1 | 2016 | 15 | 0.540 |
Why?
|
Wounds and Injuries | 2 | 2017 | 428 | 0.540 |
Why?
|
Safety-net Providers | 1 | 2016 | 58 | 0.510 |
Why?
|
Urinary Tract Infections | 2 | 2016 | 332 | 0.490 |
Why?
|
Clinical Decision-Making | 1 | 2018 | 557 | 0.490 |
Why?
|
Health Policy | 1 | 2017 | 293 | 0.480 |
Why?
|
Medicare | 2 | 2017 | 932 | 0.480 |
Why?
|
Mental Health Services | 1 | 2017 | 259 | 0.480 |
Why?
|
Appendicitis | 1 | 2016 | 176 | 0.470 |
Why?
|
Hypokalemia | 1 | 2014 | 56 | 0.460 |
Why?
|
Choice Behavior | 1 | 2016 | 255 | 0.460 |
Why?
|
Brain Ischemia | 1 | 2016 | 304 | 0.450 |
Why?
|
Gastroenteritis | 1 | 2016 | 314 | 0.450 |
Why?
|
Information Dissemination | 1 | 2016 | 275 | 0.440 |
Why?
|
Potassium | 1 | 2014 | 330 | 0.430 |
Why?
|
Program Evaluation | 1 | 2016 | 624 | 0.430 |
Why?
|
Abdominal Pain | 1 | 2015 | 376 | 0.420 |
Why?
|
Hyperkalemia | 1 | 2014 | 81 | 0.420 |
Why?
|
United States | 11 | 2024 | 16325 | 0.420 |
Why?
|
Quality of Health Care | 1 | 2017 | 643 | 0.400 |
Why?
|
Patient Readmission | 1 | 2016 | 600 | 0.390 |
Why?
|
Referral and Consultation | 1 | 2017 | 937 | 0.390 |
Why?
|
Hospitalization | 2 | 2018 | 2220 | 0.380 |
Why?
|
Diabetes Mellitus | 3 | 2016 | 1114 | 0.380 |
Why?
|
Health Services Accessibility | 1 | 2017 | 818 | 0.360 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2015 | 5458 | 0.360 |
Why?
|
Mental Disorders | 1 | 2018 | 915 | 0.350 |
Why?
|
Quality Improvement | 1 | 2017 | 929 | 0.330 |
Why?
|
Heart Arrest | 1 | 2014 | 373 | 0.330 |
Why?
|
Asthma | 1 | 2016 | 909 | 0.310 |
Why?
|
Lung Neoplasms | 11 | 2015 | 11638 | 0.290 |
Why?
|
Odds Ratio | 3 | 2017 | 2302 | 0.290 |
Why?
|
Mass Screening | 1 | 2016 | 1572 | 0.290 |
Why?
|
Radiation Oncology | 1 | 2012 | 555 | 0.280 |
Why?
|
Texas | 4 | 2018 | 6489 | 0.260 |
Why?
|
Health Care Reform | 2 | 2017 | 70 | 0.260 |
Why?
|
Pneumonectomy | 5 | 2013 | 870 | 0.230 |
Why?
|
Insurance, Health | 2 | 2016 | 262 | 0.230 |
Why?
|
Cost Savings | 1 | 2024 | 127 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2015 | 10282 | 0.220 |
Why?
|
HIV Infections | 1 | 2016 | 2223 | 0.210 |
Why?
|
Humans | 31 | 2024 | 270969 | 0.210 |
Why?
|
Male | 19 | 2024 | 127769 | 0.200 |
Why?
|
Multivariate Analysis | 4 | 2018 | 4357 | 0.200 |
Why?
|
Middle Aged | 16 | 2018 | 89661 | 0.200 |
Why?
|
Lung | 1 | 2012 | 3234 | 0.190 |
Why?
|
Forecasting | 2 | 2015 | 705 | 0.180 |
Why?
|
Adult | 13 | 2024 | 80872 | 0.180 |
Why?
|
Aged | 15 | 2018 | 73018 | 0.180 |
Why?
|
Databases, Factual | 2 | 2018 | 2314 | 0.180 |
Why?
|
Logistic Models | 2 | 2018 | 3487 | 0.170 |
Why?
|
Female | 19 | 2024 | 147624 | 0.170 |
Why?
|
Criminal Law | 1 | 2017 | 12 | 0.150 |
Why?
|
Trauma Severity Indices | 1 | 2017 | 91 | 0.150 |
Why?
|
Retrospective Studies | 11 | 2017 | 39724 | 0.150 |
Why?
|
Refusal to Treat | 1 | 2017 | 13 | 0.140 |
Why?
|
Fees and Charges | 1 | 2017 | 17 | 0.140 |
Why?
|
Skilled Nursing Facilities | 1 | 2016 | 15 | 0.140 |
Why?
|
Risk Factors | 8 | 2016 | 18036 | 0.140 |
Why?
|
Ambulances | 1 | 2016 | 24 | 0.140 |
Why?
|
Diagnosis-Related Groups | 1 | 2016 | 25 | 0.140 |
Why?
|
Patient Simulation | 1 | 2017 | 44 | 0.140 |
Why?
|
Organizational Innovation | 1 | 2017 | 73 | 0.140 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2011 | 404 | 0.140 |
Why?
|
Appointments and Schedules | 1 | 2017 | 97 | 0.140 |
Why?
|
Uncompensated Care | 1 | 2016 | 11 | 0.130 |
Why?
|
Adolescent | 4 | 2018 | 32464 | 0.130 |
Why?
|
Gallbladder Diseases | 1 | 2015 | 46 | 0.130 |
Why?
|
Hospitals, Urban | 1 | 2015 | 94 | 0.130 |
Why?
|
Confidentiality | 1 | 2016 | 126 | 0.130 |
Why?
|
Medical History Taking | 1 | 2015 | 172 | 0.120 |
Why?
|
Lost to Follow-Up | 1 | 2014 | 34 | 0.120 |
Why?
|
Program Development | 1 | 2016 | 269 | 0.120 |
Why?
|
Potassium Chloride | 1 | 2014 | 55 | 0.120 |
Why?
|
Urban Population | 1 | 2016 | 285 | 0.120 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 2487 | 0.120 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 267 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 261 | 0.110 |
Why?
|
Antihypertensive Agents | 1 | 2016 | 416 | 0.110 |
Why?
|
Bone Diseases | 1 | 2014 | 140 | 0.110 |
Why?
|
Public Health | 1 | 2016 | 303 | 0.110 |
Why?
|
Diabetes Complications | 2 | 2013 | 317 | 0.110 |
Why?
|
Patient Safety | 1 | 2018 | 678 | 0.100 |
Why?
|
Cognition | 1 | 2018 | 999 | 0.100 |
Why?
|
Substance-Related Disorders | 1 | 2017 | 549 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 608 | 0.100 |
Why?
|
Guideline Adherence | 1 | 2016 | 654 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2017 | 2048 | 0.100 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 1258 | 0.100 |
Why?
|
Bone and Bones | 1 | 2014 | 603 | 0.090 |
Why?
|
Carcinoma, Large Cell | 1 | 2011 | 99 | 0.090 |
Why?
|
Biocompatible Materials | 1 | 2011 | 211 | 0.090 |
Why?
|
Lymphatic Metastasis | 4 | 2015 | 4940 | 0.090 |
Why?
|
Mediastinum | 1 | 2012 | 276 | 0.090 |
Why?
|
Hospital Mortality | 1 | 2016 | 1403 | 0.090 |
Why?
|
Young Adult | 3 | 2018 | 22268 | 0.090 |
Why?
|
Surveys and Questionnaires | 2 | 2024 | 5952 | 0.080 |
Why?
|
Age Factors | 2 | 2016 | 5498 | 0.080 |
Why?
|
Collagen | 1 | 2011 | 753 | 0.080 |
Why?
|
Stroke | 1 | 2016 | 1185 | 0.070 |
Why?
|
Electrocardiography | 1 | 2014 | 1250 | 0.070 |
Why?
|
Myocardium | 1 | 2014 | 1343 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2016 | 30845 | 0.070 |
Why?
|
Hypertension | 1 | 2016 | 1576 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2012 | 3968 | 0.070 |
Why?
|
Ferric Compounds | 1 | 2007 | 78 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2012 | 2270 | 0.070 |
Why?
|
Neoplasm Staging | 5 | 2013 | 13883 | 0.070 |
Why?
|
Breast Implants | 1 | 2011 | 407 | 0.070 |
Why?
|
Tumor Burden | 1 | 2012 | 2020 | 0.070 |
Why?
|
Neoplasm, Residual | 1 | 2012 | 1725 | 0.070 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 4552 | 0.060 |
Why?
|
Patient Selection | 1 | 2013 | 2111 | 0.060 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2011 | 740 | 0.060 |
Why?
|
Lymph Node Excision | 1 | 2012 | 2035 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3037 | 0.060 |
Why?
|
Mammaplasty | 1 | 2011 | 792 | 0.060 |
Why?
|
Antibodies | 1 | 2007 | 845 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2012 | 1342 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 2717 | 0.060 |
Why?
|
Risk Assessment | 1 | 2016 | 7105 | 0.060 |
Why?
|
Radiosurgery | 1 | 2013 | 1376 | 0.060 |
Why?
|
Image Enhancement | 1 | 2007 | 569 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2016 | 8593 | 0.050 |
Why?
|
Time Factors | 1 | 2016 | 13261 | 0.050 |
Why?
|
Contrast Media | 1 | 2007 | 1497 | 0.040 |
Why?
|
Child, Preschool | 1 | 2016 | 16882 | 0.040 |
Why?
|
Safety Management | 1 | 2020 | 135 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 5156 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 5250 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2011 | 5094 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 959 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2015 | 15255 | 0.040 |
Why?
|
SEER Program | 2 | 2011 | 1028 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2011 | 5853 | 0.030 |
Why?
|
Survival Analysis | 3 | 2011 | 9311 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2007 | 3954 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 2013 | 98 | 0.030 |
Why?
|
Demography | 1 | 2014 | 449 | 0.030 |
Why?
|
Regression Analysis | 1 | 2014 | 1547 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2011 | 312 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 7982 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2013 | 34335 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 794 | 0.020 |
Why?
|
Vinblastine | 1 | 2010 | 460 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12475 | 0.020 |
Why?
|
Carboplatin | 1 | 2010 | 844 | 0.020 |
Why?
|
Particle Size | 1 | 2007 | 194 | 0.020 |
Why?
|
Treatment Failure | 1 | 2010 | 1430 | 0.020 |
Why?
|
Reoperation | 1 | 2011 | 1455 | 0.020 |
Why?
|
CD5 Antigens | 1 | 2007 | 122 | 0.020 |
Why?
|
Mediastinal Neoplasms | 1 | 2010 | 426 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2007 | 618 | 0.020 |
Why?
|
Length of Stay | 1 | 2013 | 2048 | 0.020 |
Why?
|
Mastectomy | 1 | 2011 | 1569 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 2281 | 0.010 |
Why?
|
Paclitaxel | 1 | 2010 | 2061 | 0.010 |
Why?
|
Cisplatin | 1 | 2010 | 2465 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 2126 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 4889 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 5893 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 3064 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 3069 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 9020 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2011 | 10092 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 9466 | 0.010 |
Why?
|
Models, Biological | 1 | 2007 | 3242 | 0.010 |
Why?
|
Rats | 1 | 2007 | 6233 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 2870 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 22348 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 16327 | 0.000 |
Why?
|
Animals | 1 | 2007 | 61175 | 0.000 |
Why?
|